Epirelefan 40 Mg 1 ml Vial

Epirelefan 40 Mg 1 ml Vial

Description:

Epirelefan 40 mg/1 ml vial is a prescription injectable corticosteroid medicine containing triamcinolone acetonide, a synthetic glucocorticoid with potent anti-inflammatory and immunosuppressive effects. It is formulated for intramuscular (i.m.) use and is commonly used in the management of various inflammatory, allergic, and autoimmune conditions when systemic corticosteroid therapy is indicated. Manufactured by EIPICO, this sterile vial is intended for professional medical use under the supervision of a healthcare provider.

Indications:

• Systemic treatment of moderate to severe inflammatory and allergic conditions responsive to corticosteroids, such as severe asthma, allergic rhinitis, and drug-induced allergic reactions (as directed by a physician).
• Adjunctive therapy in certain autoimmune and rheumatic disorders, such as rheumatoid arthritis, osteoarthritis with inflammatory components, bursitis, and tendinitis (when systemic corticosteroid therapy is appropriate).
• Management of certain dermatologic conditions requiring systemic corticosteroids, such as severe eczema, psoriasis, and dermatitis (as prescribed).
• Supportive treatment in some endocrine and collagen diseases where glucocorticoids are indicated (e.g., systemic lupus erythematosus, certain vasculitides), according to specialist guidance.
• Other conditions where a long-acting intramuscular corticosteroid is recommended by a physician.

Active Ingredients / Key Components:

• Triamcinolone acetonide – 40 mg per 1 ml vial (40 mg/ml).
• Excipients: The full list of inactive ingredients (vehicle, stabilizers, preservatives) is not available in the provided information. Please refer to the official package insert for complete excipient details.

Dosage & Administration / How to Use:

• Route of administration: Intramuscular (i.m.) injection only. Must be administered by a doctor, nurse, or qualified healthcare professional. Do not self-inject.
• Adult dosage: The dose and frequency are individualized based on the disease, severity, and patient response. Typical doses for systemic use often range from 20–80 mg i.m. at intervals determined by the physician. Exact dosing must follow the prescribing doctor’s instructions and official guidelines.
• Pediatric use: Use in children is at the discretion of a pediatric specialist. Dose is usually lower and based on body weight and condition. Safety and dosing must strictly follow medical advice.
• Administration technique: Inject deeply into a large muscle mass (e.g., gluteal muscle) using aseptic technique. Avoid intravascular injection. Rotate injection sites if repeated doses are required.
• Duration of treatment: Short-term or intermittent use is preferred. Long-term systemic corticosteroid therapy should be regularly reviewed and tapered gradually when discontinuing, as directed by the physician.
• With or without food: As this is an injectable product, timing with meals is not applicable; however, patients should follow general corticosteroid advice given by their doctor.
• Do not adjust the dose, frequency, or duration without consulting your healthcare provider. Never share this medication with others.

Clinical Benefits:

• Provides potent anti-inflammatory action by inhibiting phospholipase A2 and reducing the production of prostaglandins, leukotrienes, and platelet-activating factor.
• Offers strong immunosuppressive effects by modulating cytokine gene expression, helping control autoimmune and allergic responses.
• Helps relieve symptoms such as pain, swelling, redness, and stiffness associated with inflammatory and rheumatic conditions.
• Long-acting intramuscular formulation can provide prolonged systemic corticosteroid effect, potentially reducing the need for frequent dosing in selected patients.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to triamcinolone acetonide or any component of the formulation.
• Generally contraindicated in systemic fungal infections and in patients receiving live or live-attenuated vaccines while on significant immunosuppressive doses of corticosteroids.
• Use with extreme caution in patients with uncontrolled diabetes mellitus, hypertension, peptic ulcer disease, severe osteoporosis, glaucoma, cataracts, psychiatric disorders, or a history of tuberculosis or serious infections.
• Long-term or high-dose use may cause adrenal suppression; abrupt discontinuation after prolonged therapy may lead to adrenal insufficiency. Tapering under medical supervision is required.
• May mask signs of infection and increase susceptibility to bacterial, viral, fungal, or parasitic infections.
• Consult your doctor before use if pregnant or nursing; systemic corticosteroids should be used in pregnancy and lactation only if the potential benefit justifies the potential risk to the mother and baby.
• Use with caution in children, as prolonged systemic corticosteroid therapy can affect growth and development.
• Monitor blood pressure, blood glucose, electrolytes, and eye health in patients on repeated or long-term treatment.
• Consult your doctor before use if you are taking other medications such as anticoagulants, antidiabetics, NSAIDs, diuretics, certain vaccines, or other immunosuppressants due to potential interactions.
• Not intended to diagnose, treat, cure, or prevent any disease without a doctor’s prescription and supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects with systemic corticosteroids may include fluid retention, increased appetite, weight gain, mood changes, insomnia, elevated blood pressure, and increased blood glucose.
• Long-term use may lead to Cushingoid features (moon face, central obesity), osteoporosis, muscle weakness, skin thinning, easy bruising, delayed wound healing, and increased infection risk.
• Gastrointestinal effects such as stomach irritation, nausea, or peptic ulcer may occur, especially with concomitant NSAID use.
• Ocular side effects with prolonged use can include glaucoma, cataracts, and increased intraocular pressure.
• Serious allergic reactions (rash, itching, swelling of face/tongue/throat, severe dizziness, difficulty breathing) are rare but require immediate medical attention.
• Contact your doctor promptly if you experience severe or persistent side effects, mood or behavior changes, vision problems, signs of infection (fever, sore throat), or unusual fatigue.

Storage Instructions:

Store in a cool, dry place away from direct sunlight, typically below 25°C or as stated on the package insert. Do not freeze. Keep the vial in its original packaging until use. Keep container tightly closed and out of reach of children. Do not use after the expiry date printed on the pack. Discard any unused portion according to local regulations.

Specifications:

• Product type: Prescription injectable corticosteroid medicine.
• Strength: 40 mg triamcinolone acetonide per 1 ml (40 mg/ml).
• Form: Sterile intramuscular injection vial.
• Volume: 1 ml single-use vial.
• Route of administration: Intramuscular (i.m.) only, by healthcare professionals.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.